What question did this study set out to answer?

This research aims to explore the functional significance of the Tropomyosin 3 isoform in cardiac performance.

October 1, 2002AJP Heart and Circulatory Physiology

Tropomyosin 3 expression leads to hypercontractility and attenuates myofilament length-dependent Ca²⁺activation

Q: What is the clinical evidence from this study?

Population: Transgenic mice expressing TPM 3. Intervention: Ectopic expression of TPM 3 isoform vs. Wild-type mice. Primary outcome: Cardiac performance and sarcomeric function.

View Full Paper

Ask AI

Bookmark

Key result

Ectopic expression of the TPM 3 isoform in transgenic mice caused a hyperdynamic effect on cardiac function, decreased Ca2+ sensitivity, and attenuated length-dependent Ca2+ activation.

Population

Transgenic mice (six lines) with ectopic expression of TPM 3 in the heart

Comparison

Ectopic expression of TPM 3 protein vs Non-transgenic controls (implied)

Design

Preclinical

Authors

KPKathy PieplesLaboratory of Molecular Genetics GAGrace M. ArteagaMayo Clinic RSR. John SolaroGeneral Cardiology

Discussion

Member takes

Implication

TPM3 transgenic findings in mice should not alter clinical practice; leaves open isoform contributions to human contractile disorders.

Key Points

This research aims to explore the functional significance of the Tropomyosin 3 isoform in cardiac performance.
Generated six transgenic mouse lines with varying levels of Tropomyosin 3 expression, accounting for 40-60% of total tropomyosin.
Conducted physiological assessments using closed-chest analyses and work-performing models.
Analyzed fiber bundles to evaluate sensitivity to calcium and length-dependent calcium activation.
Transgenic mice exhibited hyperdynamic systolic and diastolic function, indicating altered cardiac performance.
Decreased sensitivity to calcium in force generation was observed.
Length-dependent calcium activation was significantly reduced without changes in interfilament spacing.

Structured PICO

Population

Transgenic mice ectopically expressing the TPM 3 isoform in the heart to determine its functional significance.

Intervention

Ectopic expression of TPM 3 protein (accounting for 40-60% of total striated muscle tropomyosin)

Comparator

Non-transgenic controls (implied)

Outcome

Cardiac performance (systolic and diastolic function) and myofilament Ca2+ sensitivitysurrogate

Ectopic expression of the TPM 3 isoform in mouse hearts alters sarcomeric performance by decreasing Ca2+ sensitivity and length-dependent Ca2+ activation, leading to hypercontractility.

Cite This Study

Pieples et al. (2002) studied Transgenic mice expressing TPM 3. Ectopic expression of TPM 3 isoform vs. Wild-type mice was evaluated on Cardiac performance and sarcomeric function. Ectopic expression of the TPM 3 isoform in transgenic mice caused a hyperdynamic effect on cardiac function, decreased Ca2+ sensitivity, and attenuated length-dependent Ca2+ activation.

synapsesocial.com/papers/6a240be99e1c90a91c099b27 https://doi.org/10.1152/ajpheart.00351.2002

View Full Paper

Ask AI

Bookmark

Tropomyosin 3 expression leads to hypercontractility and attenuates myofilament length-dependent Ca²⁺activation

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Tropomyosin 3 expression leads to hypercontractility and attenuates myofilament length-dependent Ca²⁺activation

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider